FDA Investigator Robert Darius

Robert Darius has inspections in 1 countries as of 14 Sep 2023. Robert Darius has collaborated with a combinined 2244 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
2
Last Inspection Date:
14 Sep 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America
Co-Investigator(s):
Adaliz Santaliz Cruz, Alan A Rivera, Amalia C Himaya, Amalia Himaya, Andrea George, PhD, Anita Narula, PhD, Arlene M Badillo, Ashley N Queen, PhD, Barry Cherney, PhD, Bichsa T Nguyen, Bichsa T Tran, Bo Chi, PhD, Brien C Fox, Calvin B Koerner, Carla J Lundi, Caryn M Mcnab, Cheron M Portee, Christina V Santos, Christopher Downey, PhD, Colleen Thomas, PhD, Daniel W Cline, Davinna Ligons, PhD, Dennis Cantellops Paite, Diane Cvan Leeuwen, Doan T Nguyen, PharmD, Donald C Obenhuber, PhD, Donna Ltartaglino Besone, Dov Pluznik, PhD, Eliezar Ramos, Erika V Butler, Frances Namuswe, PhD, Haley H Seymour, Haley Seymour, Haroon Vohra (NMI), Hasan A Irier, PhD, Iris C Macinnes, Ivis Lnegron Torres, James R Fleckenstein, Jee Chung, PhD, Jeffrey P Raimondi, Jennifer Gogley, Jennifer Lalama, Jennifer M Gogley, Jerri Baker, Joel Welch, PhD, John R Myung, Jorge L Lajara, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose R Lopez, Jose Velez, Jun Park, PhD, Ka L Wong, Kathleen R Jones, PhD, Kelvin Cheung, Kelvin X Sanders, Kendra A Biddick, Kim Lthomas Cruse, Laura Fontan, MS, Leonard H Lavi, Libia M Lugo, LT Rafael Gonzalez, Marcia Britt Williams, Marcus F Yambot, Maria Gutierrez Lugo, PhD, Marian E Ramirez, Maxwell Van Tassell, PhD, Maxyne T Lam, Michael A Charles, Michael Shanks, MS, Michelle A Marsh, Michelle Y Clark Stuart, Mihaly S Ligmond, Milva E Melendez, Milva Emelendez Perales, Mohsen Rajabi Abhari, FDA, Myriam M Sosa, Nicholas Obiri, PhD, Nicola M Fenty Stewart, Nikolay Spiridonov, Noreen Muniz, Noreen Muñiz, Nydia E Colon, Omotunde O Osunsanmi, Patricia Fhughes Troost, Paul Z Balcer, Paula A Trost, Peter S Diak, Ramesh Potla, PhD, Ramon A Hernandez, Rebecca E Dombrowski, Rebecca Parrilla, Rebecca Rodriguez, Richmond K Yip, Riley C Myers, PhD, Robert D Tollefsen, Roger F Zabinski, Ronald L Koller, Ronda Lebland, Sarah Arden, Scott R Nichols, PhD, Sidney B Priesmeyer, Sonia R Peterson, Stanley Au, Steven C Madzo, Steven Fong, MS, PhD, Taichun Qin, PhD, Terri L Dodds, Thao T Kwan, Thao Tran, Thao X Tran, Thomas J Arista, Timothy Wadkin, PhD, Uttaniti Limchumroon (Tom), Vilmary Negron Rodriguez, Wendy G Tan, PhD, Yumi J Hiramine, Yvonne C Wilkes, Zachary L Stamm, Zhihao Qiu (Peter), PhD, Zhong Li, PhD

Robert Darius's Documents

Publish Date Document Type Title
October, 2000 FDA 483 Amgen, Inc - Form 483, 2000-10-20
October, 2000 EIR Amgen Manufacturing Ltd - EIR, 2000-10-20

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more